国产99精品,国产精品v,99热精品国产三级在线观看,免费精品,国产精品一区在线观看,精品国产第一页,国产精品一区在线观看

首頁 /科研細胞 /人源細胞系 /其他人源細胞系 /NTERA-2 cl.D1(人睪丸癌細胞)

NTERA-2 cl.D1(人睪丸癌細胞)

CBP60680

詢 價
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
I. General information 
Synonyms: NTERA-2 cl.D1
Background: The parental NTERA-2 lines was established in 1980 from a nude mouse xenograft of the Tera-2 cell line (see ATCC HTB-106). The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line.
Species: Homo sapiens, human
Tissue: testis; derived from metastatic site: lung
Disease: malignant pluripotent embryonal carcinoma
Gender: Caucasian, male, 22 years 
Morphology: epithelial-like,differentiation changes phenotype
Growth Mode: adherent
DNA Profile: Amelogenin: X,Y
CSF1PO: 10,12
D13S317: 13
D16S539: 11,12,13
D5S818: 9,12
D7S820: 10,12
THO1: 9.3
TPOX: 8
vWA: 18,19
Cobioer’s Cell Line Authentication Service
Culture Medium:

DMEM +10%FBS

NTERA-2 cl.D1完全培養(yǎng)基,# CBP60680M
We strongly suggest to purchase the complete medium from Cobioer.

Cryopreservation medium: 90%FBS+10%DMSO
Comments: This clone differentiates along neuroectodermal lineages after exposure to retinoic acid (RA) or hexamethylene bisacetamide (HMBA).The RA induced differentiation is characterized by glycolipid changes, appearance of neurons, and induction of homeobox (HOX) gene clusters.
The cells exhibit high expression of N-myc oncogene activity.To induce differentiation, the cells should be trypsinized and seeded at a density 1 X 10 exp6 cells per 75 sq. cm. in medium containing 0.01 mM trans-retinoic acid. Stock solutions of trans-retinoic acid (10 mM, dissolved in DMSO) should be stored frozen (preferably under a nitrogen atmosphere).
For more information, please contact Cobioer (4008-750-250).

客服

微信

掃一掃,添加二維碼

電話

留言

藥靶模型聯(lián)系方式: 華東銷售經(jīng)理:18240630236 全國銷售經(jīng)理:18066071954
診斷標準品聯(lián)系方式: 華東銷售經(jīng)理:15000320447 華北銷售經(jīng)理:18131625521 華南銷售經(jīng)理:13484295986 華中&西南銷售經(jīng)理:13871580511 全國銷售經(jīng)理:13484295986

掃二維碼

立即提交